Informatica (INFA) has resumed trading following its giant Q2 warning. Shares are down 26.2%. Some of Informatica's more volatile enterprise software peers also aren't taking the news well. QLIK -3.2%. MSTR -1.4%. RHT -1.1%. VMW -1.2%. CTXS -1.4%. CRM -1.7%. [View news story]
pushed in a big put order after hours . I hope it gets executed.
Bio Pharma Potential Big Movers For Thursday, June 28 [View article]
Scott, I was doing DD on VVUS . I am kinda surprised that FDA will consider to approve it esp. when there are strong chances that this might get abused and insufficient research on pills affect in long term. I am not completely convinced that it should/will get approved.
NuPathe Facts On A Very Undervalued Play [View article]
again.
NuPathe Facts On A Very Undervalued Play [View article]
I can refer Scott's older article on it and say it might double in few months :-).
Salesforce.com: Not So 'Amazing, Great, Incredible' [View article]
Body Central Offering Growth And Value On Sale [View article]
Salesforce.com Grossly Overvalued [View article]
Stem Cell Therapy: The Investment Of The Future [View article]
Stem Cell Therapy: The Investment Of The Future [View article]
Salesforce.com Grossly Overvalued [View article]
Today's Pharma Buzz: Avon Files Interesting 8k, Amarin And Vivus Approach FDA Approvals [View article]
what do you think ?
Salesforce.com Grossly Overvalued [View article]
Earnings Preview: Infosys Limited [View article]
. buying more bear puts.
Informatica (INFA) has resumed trading following its giant Q2 warning. Shares are down 26.2%. Some of Informatica's more volatile enterprise software peers also aren't taking the news well. QLIK -3.2%. MSTR -1.4%. RHT -1.1%. VMW -1.2%. CTXS -1.4%. CRM -1.7%. [View news story]
Today's Pharma Buzz: Avon Files Interesting 8k, Amarin And Vivus Approach FDA Approvals [View article]
Bio Pharma Potential Big Movers For Thursday, June 28 [View article]
I was doing DD on VVUS . I am kinda surprised that FDA will consider to approve it esp. when there are strong chances that this might get abused and insufficient research on pills affect in long term.
I am not completely convinced that it should/will get approved.
Somebody Is Very Wrong About Nokia [View article]
http://bit.ly/Lretx3